Currently available human papillomavirus (HPV) detection devices are expensive, requiring a continuous power supply, high-priced reagents, skilled laboratory personnel, and infrastructure. These make ...
At the AOGIN, Seegene presented its advanced technologies for identifying viruses linked to cervical cancer. The company organized an exhibition booth and hosted a symposium session under the theme of ...
Human Papillomavirus (HPV) Simplicity Panel™ delivers a reliable, lab-ready solution for studying 14 high-risk HPV types in a streamlined research format BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ - ...
Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...
Human papillomavirus (HPV) is a DNA virus known to cause infections in mucous membranes and skin, typically resulting in warty lesions. While often benign, these lesions do have the potential to ...
Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing CoSara is currently supporting the second phase of the Company's preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback